Hemophilia patients share their thoughts on a new Needle-Free option
NCT ID NCT06992076
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study is for 100 adults and teens with hemophilia who are already taking marstacimab. Researchers want to know if patients prefer a simple shot under the skin instead of the usual IV treatment. They will also measure how much the treatment affects daily life and track bleeding episodes over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of haematology and Blood diseases hospital
RECRUITINGTianjin, Tianjin Municipality, China
Contact
Contact
-
The First Affiliated Hospital of Xiamen University
RECRUITINGXiamen, Fujian, China
Contact
Conditions
Explore the condition pages connected to this study.